Juan J Soler-Cataluna
Overview
Explore the profile of Juan J Soler-Cataluna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calle Rubio M, Miravitlles M, Lopez-Campos J, Soler-Cataluna J, Navarrete B, Fuentes-Ferrer M, et al.
J Clin Med
. 2024 Feb;
13(4).
PMID: 38398268
Background: Alpha-1 antitrypsin deficiency (AATD) is an underdiagnosed condition despite being one of the most common inherited disorders in adults that is associated with an increased risk of developing chronic...
2.
Tarraso J, Safont B, Carbonell-Asins J, Fernandez-Fabrellas E, Sancho-Chust J, Naval E, et al.
Respir Res
. 2022 Sep;
23(1):242.
PMID: 36096801
Background: The coronavirus disease (COVID-19) pandemic has already affected more than 400 million people, with increasing numbers of survivors. These data indicate that a myriad of people may be affected...
3.
Orozco-Beltran D, Arriero-Marin J, Carratala-Munuera C, Soler-Cataluna J, Lopez-Pineda A, Gil-Guillen V, et al.
J Clin Med
. 2021 Apr;
10(7).
PMID: 33917437
The prevalence of chronic obstructive pulmonary disease (COPD) is rising faster in women in some countries. An observational time trends study was performed to assess the evolution of hospital admissions...
4.
Garcia Castillo E, Alonso Perez T, Ancochea J, Pastor Sanz M, Almagro P, Martinez-Camblor P, et al.
ERJ Open Res
. 2020 Dec;
6(4).
PMID: 33263033
In 2019, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) modified the grading system for patients with COPD, creating 16 subgroups (1A-4D). As part of the COPD Cohorts Collaborative...
5.
Alonso Perez T, Garcia Castillo E, Ancochea J, Pastor Sanz M, Almagro P, Martinez-Camblor P, et al.
Respir Med
. 2020 Aug;
171:106105.
PMID: 32858497
Background: There is partial evidence that COPD is expressed differently in women than in men, namely on symptoms, pulmonary function, exacerbations, comorbidities or prognosis. There is a need to improve...
6.
Almagro P, Martinez-Camblor P, Miravitlles M, Rodriguez-Carballeira M, Navarro A, Lamprecht B, et al.
COPD
. 2019 Mar;
16(1):8-17.
PMID: 30870059
The CODEX index was developed and validated in patients hospitalized for COPD exacerbation to predict the risk of death and readmission within one year after discharge. Our study aimed to...
7.
Calle Rubio M, Soriano J, Lopez-Campos J, Soler-Cataluna J, Navarrete B, Rodriguez Gonzalez-Moro J, et al.
PLoS One
. 2019 Feb;
14(2):e0212522.
PMID: 30753244
[This corrects the article DOI: 10.1371/journal.pone.0198777.].
8.
Lopez-Campos J, Navarrete B, Soriano J, Soler-Cataluna J, Rodriguez Gonzalez-Moro J, Ferrer M, et al.
Int J Chron Obstruct Pulmon Dis
. 2018 Aug;
13:2279-2288.
PMID: 30100718
Purpose: Current COPD management recommendations indicate that pharmacological treatment can be stepped up or down, but there are no recommendations on how to make this adjustment. We aimed to describe...
9.
Calle Rubio M, Soriano J, Lopez-Campos J, Soler-Cataluna J, Navarrete B, Rodriguez Gonzalez-Moro J, et al.
PLoS One
. 2018 Jun;
13(6):e0198777.
PMID: 29953442
Background: Alpha-1 antitrypsin deficiency (AATD) is the most common hereditary disorder in adults, but is under-recognized. In Spain, the number of patients diagnosed with AATD is much lower than expected...
10.
Guerra B, Haile S, Lamprecht B, Ramirez A, Martinez-Camblor P, Kaiser B, et al.
BMC Med
. 2018 Mar;
16(1):33.
PMID: 29495970
Background: External validations and comparisons of prognostic models or scores are a prerequisite for their use in routine clinical care but are lacking in most medical fields including chronic obstructive...